CardioGenics Holdings Inc (CGNH)

Market Cap	14.29K
Revenue (ttm)	n/a
Net Income	-980.79K
EPS	-0.01
Shares Out	142.86M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,066
Average Volume	371,333
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.0000 - 0.0002
Beta	111.31
RSI	51.39
Earnings Date	n/a

About CardioGenics Holdings

CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are u...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1997
• Employees: 4
• Stock Exchange: OTCMKTS
• Ticker Symbol: CGNH